Here are relevant reports on : antibody-drug-conjugates-market
-
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029
The global AI in drug discovery market, valued at US$1.39 billion in 2023, stood at US$1.86 billion in 2024 and is projected to advance at a resilient CAGR of 29.9% from 2025 to 2029, culminating in a forecasted valuation of US$6.89 billion by the end of the period. The growth of this market is primarily driven by the growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, and the increasing focus on oncology indication.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Mouth Ulcer Treatment Market by Drug Type (Antimicrobial, Analgesic, Antihistamine, Corticosteroids, Anesthetic), Formulation (Mouthwash, Lozenges, Ointment, Spray, Gel), Indication (Aphthous Stomatitis, Oral Lichen Planus) - Global Forecast to 2023
Mouth ulcers, also called as canker sores, are painful sores that are formed on the soft tissue in the mouth including lips, cheek, tongue, floor and roof of the mouth, and gums. Mouth ulcers can make it difficult for some patients to eat, drink, and brush teeth. Most mouth ulcers are benign and recurring and get cleared up within 1-2 weeks on their own. Some common causes of mouth ulcer are acidic foods, biting the tongue or inside of the cheek, braces, poor-fitting dentures, and other apparatus that may rub against the mouth and gums, deficiency of vitamins, stress, anxiety, infections, and may be a sign of other diseases such as Crohn's disease, celiac disease, or HIV.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Federated Learning Market by Application (Drug Discovery, Industrial IoT, Risk Management), Vertical (Healthcare and Life Sciences, BFSI, Manufacturing, Automotive and Transportation, Energy and Utilities) and Region - Global Forecast to 2028
As per AS-IS scenario, the global federated learning market size is projected to reach worth $210 million by 2028, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period. The federated learning solutions vendors have implemented various types of organic as well as inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global federated learning solutions market include NVIDIA (US), Cloudera (US), IBM (US), Microsoft (US), Google (US), Intel(US), Owkin(US), Intellegens(UK), Edge Delta(US), Enveil(US), Lifebit(UK), DataFleets(US), Secure AI Labs(US), and Sherpa.AI(Spain).
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region - Global Forecast to 2026
The High Performance Medical Plastics Market is expected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period. Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US), among others are the key players operating in the high performance medical plastics market.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]- Forecast to 2031
The Europe Pharmaceutical drug delivery market, valued at US$501.6 million in 2025, stood at US$519.6 million in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of US$703.2 million by the end of the period. The major trends in this market are self-administration, technology-driven drug delivery, sustainable drug delivery, and drug device combinations.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
North America Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Prefilled Syringes), Packaging Type (Primary, Secondary), Drug Delivery (Oral, Injectables), Raw Material (Plastics, Paper & Paperboard), and Country - Forecast to 2030
The North America pharmaceutical packaging market is projected to grow from USD 57.26 billion in 2025 to USD 114.33 billion by 2030, at a CAGR of 14.8% during the forecast period. The key players in the pharmaceutical packaging market in North America include AptarGroup, Inc. (US), Becton Dickinson & Co. (BD) (US), West Pharmaceutical Services, Inc. (US), WestRock (US), Catalent, Inc. (US), Sealed Air Corporation (US), CCL Industries (US), and Owens-Illinois, Inc. (O-I Glass) (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
